Posted by tizza on April 11, 2006, at 19:47:42
In reply to Re: agomelatine (Valdoxan) - Application to FDA?, posted by ravenstorm on April 11, 2006, at 10:47:13
I looked into this a couple of months ago and from whay I can gather it was only phase 3 in the EU. There isn't very much info around about it. Probably because if it can do what they're saying it can, it will blow all other AD's out of the water. It's all very interesting. Maybe the want to keep it reasonably quite until they get it on the market. Who knows, Paul
poster:tizza
thread:479920
URL: http://www.dr-bob.org/babble/20060408/msgs/631924.html